| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| R&D Expense | $126.5M | +59.1% |
| SG&A Expense | $50.6M | +30.4% |
| Operating Income | -$177.1M | -49.7% |
| Interest Expense | $2.0M | — |
| Pre-tax Income | -$174.0M | -47.4% |
| Income Tax | $288K | — |
| Net Income | -$174.3M | -47.7% |
| EPS (Basic) | -$2.99 | -32.3% |
| EPS (Diluted) | -$2.99 |
| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $146.6M | +38.4% |
| Short-term Investments | $436.8M | +50.8% |
| Current Assets | $592.6M | +46.7% |
| Total Assets | $646.6M | +40.2% |
| Current Liabilities | $33.8M | +63.0% |
| Long-term Debt | $28.6M | — |
| Total Liabilities | $91.3M | +82.7% |
| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$128.1M | -55.8% |
| Capital Expenditures | $2.3M | -2.8% |
| Investing Cash Flow | -$142.5M | -7790.5% |
| Financing Cash Flow | $311.3M | +4618.1% |
| Free Cash Flow | -$130.3M | -54.2% |
| -32.3% |
| Stockholders' Equity |
| $555.3M |
| +35.0% |